First steps toward male infertility treatment

March 28, 2017 by Grant Hill, University of Dundee
Credit: University of Dundee

Scientists from the University of Dundee believe they have taken the first steps towards developing drugs to treat infertile men.

Infertility is a significant problem affecting tens of millions of couples worldwide, with around half of cases having a male factor either as a sole or contributory cause. It is known that asthenozoospermia (poor/dysfunctional motility) is the commonest disorder in male infertility, yet there is no drug that men can currently take for it to improve the chances of conception.

As such, couples who require assistance to conceive need to rely on clinical treatments such as In vitro fertilisation (IVF) or (ICSI), both of which are expensive, invasive and are not guaranteed to work.

While there is clearly an unmet need for alternative treatments for male subfertility, the time, effort and resources required for drug discovery are currently exorbitant. The cellular, physical and functional properties of human spermatozoa present unique challenges to researchers and the lack of an appropriate platform to analyse potential treatments further complicates the issue.

Now the Dundee team have developed and validated a high throughput screening (HTS) method that may help to find novel agents that improve sperm function. HTS automates the experimentation process to allow researchers to quickly identify active compounds, antibodies, or genes relevant to their work.

While a cure for remains some way off, the researchers, led by Dr Sarah Martins da Silva, believe their method has removed many of the barriers towards developing drugs to treat the condition.

"Male infertility is incredibly common but there is nothing we can currently prescribe in the vast majority of cases," said Dr Martins da Silva. "The problem is that we really don't understand how sperm function. And because we don't really understand how they function, then we don't know how to correct sperm dysfunction either.

"The other issue is that sperm are absolutely unique cells, designed to survive outside the body and hugely specialised to swim, find and fertilise an egg. They are small and have virtually no cytoplasm, and the cell signalling pathways can be unlike other cells. As a result, sperm are incredibly challenging to study. We believe we have now taken the first steps towards helping millions of couples worldwide."

It is known that alterations in intracellular calcium are fundamental to sperm function, including swimming and fertilisation, and that fluctuations in calcium are due, in large part, to a sperm-specific channel named CatSper (Cation channel of sperm).

In the absence of a known specific molecular or receptor target, compound library high-throughput screening (HTS) is an alternative approach that has developed in recent decades.

Dr Martins da Silva and her colleagues worked with the University's Drug Discovery Unit (DDU) to create a high-throughput assay platform to monitor intracellular calcium responses in sperm as a surrogate for sperm motility.

"This enabled us to identify hit compounds, which we were able to test on sperm and saw improved functional motility," continued Dr Martins da Silva. "We also saw enhanced functional motility when we tested two of the compounds on patient samples, which is exciting and hugely relevant for patients, albeit this is still very early days."

As the CatSper channel is unique to sperm, identifying a therapeutic compound for it potentially avoids systemic side-effects, making these candidates very attractive both clinically and commercially.

Having concluded that HTS can robustly and efficiently identify novel compounds that increase intracellular calcium in human spermatozoa and improve function, the researchers propose to use it as a cornerstone to drive forward for male subfertility.

The paper has been published online by the Human Reproduction journal.

Explore further: Males conceived via fertility treatment may have weakened sperm: study

More information: Sarah J. Martins da Silva et al. Drug discovery for male subfertility using high-throughput screening: a new approach to an unsolved problem, Human Reproduction (2017). DOI: 10.1093/humrep/dex055

Related Stories

Males conceived via fertility treatment may have weakened sperm: study

October 7, 2016
(HealthDay)—Males who were conceived using an infertility treatment where sperm is injected into an egg may themselves have lower sperm quantity and quality than those conceived naturally, Belgian researchers report.

Some sunscreen ingredients may disrupt sperm cell function

April 1, 2016
Many ultraviolet (UV)-filtering chemicals commonly used in sunscreens interfere with the function of human sperm cells, and some mimic the effect of the female hormone progesterone, a new study finds. Results of the Danish ...

Study reveals gene's role in male infertility

October 13, 2016
A Virginia Commonwealth University-led research team has opened a fresh direction in the field of male infertility with a new study that examines the role of a particular gene in the formation of sperm flagella, which is ...

New sperm research could lead to cut in infertility rate

October 31, 2016
Sperm and mathematics don't appear to be the likeliest of bedfellows - but new research bringing the two together could lead to devices that could cut infertility rates.

Recommended for you

New era for blood transfusions through genome sequencing

May 18, 2018
Most people are familiar with A, B, AB and O blood types, but there are hundreds of additional blood group "antigens" on red blood cells—substances that can trigger the body's immune response—that differ from person to ...

Robots grow mini-organs from human stem cells

May 17, 2018
An automated system that uses robots has been designed to rapidly produce human mini-organs derived from stem cells. Researchers at the University of Washington School of Medicine in Seattle developed the new system.

Scientists uncover a new face of a famous protein, SWI2/SNF2 ATPase

May 17, 2018
A team of Texas A&M and Texas A&M AgriLife Research scientists now have a deeper understanding of a large switch/sucrose non-fermentable (SWI/SNF) protein complex that plays a pivotal role in plant and human gene expression ...

Antibacterial in your toothpaste may combat severe lung disease

May 17, 2018
A common antibacterial substance found in toothpaste may combat life-threatening diseases such as cystic fibrosis, or CF, when combined with an already FDA-approved drug.

Blocking two enzymes could make cancer cells mortal

May 17, 2018
EPFL scientists have identified two enzymes that protect chromosomes from oxidative damage and shortening. Blocking them might be a new anticancer strategy for stopping telomerase, the enzyme that immortalizes tumors.

Emergency contact information helps researchers branch out family tree

May 17, 2018
When you go to the doctor or hospital, one piece of information that you're always asked to provide—in addition to your name, address, and insurance information—is an emergency contact. Often, that person is a blood relative. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.